Skip to content

The Effects of Calorie Restriction With or Without Metformin on Weight and Insulin Resistance

The Effects of Calorie Restriction - Whether or Not Calculated Based on BMR (Basic Metabolic Rate) - With or Without Metformin on Weight and Insulin Resistance of Obese Insulin Resistant Patients

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00134290
Enrollment
48
Registered
2005-08-24
Start date
2002-01-31
Completion date
2004-05-31
Last updated
2007-12-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Body Weight, Insulin Resistance

Brief summary

This is a study to: * Determine the difference between strong hypo-energetic standard diet advice and modest hypo-energetic personal diet advice; and * Determine the influence of insulin-insensitivity on obesity and weight reduction by treating patients with metformin or placebo.

Detailed description

The aim of the present study was to determine what the difference is of a strong hypo-energetic standard diet advice and a modest hypo-energetic personal diet advice which was determined by the energy needs of a person as calculated with a combination of basal metabolic rate (BMR) and physical activity level (PAL) on weight loss and insulin sensitivity. Secondly, this study wanted to determine what the influence is of insulin-insensitivity on obesity and weight reduction by treating the patients with metformin or placebo. The subjects were therefore randomised into two double blinded groups receiving either metformin (2 x 850 mg per day) or placebo in combination with a moderate energy restriction and a exercise regimen of 30 minutes per day for 1 year. Treatment effects of both diets and the effect of metformin on weight reduction and insulin sensitivity were determined after a treatment period of 20 and 52 weeks. Insulin sensitivity was quantified using the homeostasis model assessment (HOMA) and the OGTT. Body composition was determined with the bioelectrical impedance method. Blood was also drawn for hormonal and biochemical analyses after 20 and 52 weeks of treatment. Furthermore, the patients had to fill out a 3-day food diary at baseline, after 20 weeks and after 52 weeks.

Interventions

DRUGmetformin
BEHAVIORALstandard diet advice
BEHAVIORALpersonal diet advice

Sponsors

University Hospital, Ghent
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE

Eligibility

Sex/Gender
ALL
Age
20 Years to 55 Years
Healthy volunteers
No

Inclusion criteria

* 20-55 years of age * Body mass index (BMI) equal to or greater than 30 kg/m² * Insulin resistance as determined by oral glucose tolerance test (OGTT) and HOMA

Exclusion criteria

* Diabetes mellitus, kidney insufficiency, or hepatic insufficiency * Hypogonadism with other etiology than overweight * Pregnancy * BMI equal to or greater than 40 kg/m²

Design outcomes

Primary

MeasureTime frame
Effect of diet on weight and insulin sensitivity/insulin resistance after 20 and 52 weeks of treatment

Secondary

MeasureTime frame
Effect of metformin on weight and insulin resistance after 20 and 52 weeks of treatment

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026